Skip to site menu Skip to page content

Daily Newsletter

11 February 2025

Daily Newsletter

11 February 2025

TidalSense scores grant for children’s asthma diagnostic development

TidalSense plans to use the funds to continue its work on developing AI algorithms to help diagnose asthma in young children.

Ross Law February 10 2025

TidalSense has received a £795,000 grant from the UK's Small Business Research Initiative (SBRI) Healthcare programme to support the continued development of its N-Tidal device for diagnosing asthma in young children.

N-Tidal measures the amount of carbon dioxide (CO₂) in a patient's breath during normal breathing using a CO₂ sensor, with AI algorithms then applied to analyse breath patterns as a means of diagnosing asthma.

Asthma is more traditionally diagnosed using a spirometry test that assesses an individual’s lung function. However, such a test is often challenging for children to perform due to the specific movements and inhalations required for adequate data capture.

TidalSense plans to launch its tool, which was successfully tested in a pilot research programme last year, demarcating the first phase of the company’s project, onto its AI medical device diagnostic platform. The company claims that once ready, N-Tidal will make diagnosing asthma in children easier and more accurate.

Last year’s pilot for N-Tidal was conducted in collaboration with the University of Nottingham and Nottingham University Hospitals National Health Service (NHS) Trust. The project, which was also funded by SBRI, successfully demonstrated the use of N-Tidal in healthy children and those with wheezing or paediatric asthma as young as five years old.

Asthma is the most common long-term condition among children and young people, according to the Royal College of Paediatrics and Child Health. Around one in 11 children and young people live with the chronic lung disease.

TidalSense CEO Dr Ameera Patel commented: “[Asthma is a] particularly difficult condition to diagnose in children because current diagnostic tools often require children to perform special breathing manoeuvres, which can be difficult for them to do."

Patel said that new diagnostic tools and pathways such as N-Tidal are easy for the patient to perform, with no requirement for complex medical analysis.

She added: “This means that the tests can be performed by generalist medical staff in primary care settings, making access to healthcare more easily accessible, and also more comfortable for the patient."

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close